Bruker Corporation

BOVESPA:B2RK34 Stock Report

Market Cap: R$54.8b

Bruker Past Earnings Performance

Past criteria checks 2/6

Bruker has been growing earnings at an average annual rate of 16.3%, while the Life Sciences industry saw earnings growing at 15.2% annually. Revenues have been growing at an average rate of 10.2% per year. Bruker's return on equity is 16.5%, and it has net margins of 9.4%.

Key information

16.3%

Earnings growth rate

17.6%

EPS growth rate

Life Sciences Industry Growth19.5%
Revenue growth rate10.2%
Return on equity16.5%
Net Margin9.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Bruker makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BOVESPA:B2RK34 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243,241305855356
30 Jun 243,120352804329
31 Mar 243,001402762308
31 Dec 232,965427730295
30 Sep 232,818319687275
30 Jun 232,715319644260
31 Mar 232,621312625248
31 Dec 222,531297608236
30 Sep 222,506275598231
30 Jun 222,476274605226
31 Mar 222,458282577223
31 Dec 212,418277563221
30 Sep 212,362270544220
30 Jun 212,264238518216
31 Mar 212,118204485204
31 Dec 201,988158472198
30 Sep 201,960158470188
30 Jun 201,970165480185
31 Mar 202,035177503190
31 Dec 192,073197500188
30 Sep 192,026207491186
30 Jun 191,972189473182
31 Mar 191,925184459177
31 Dec 181,896180449173
30 Sep 181,87398443172
30 Jun 181,84292440171
31 Mar 181,81384432167
31 Dec 171,76679420162
30 Sep 171,706151407157
30 Jun 171,664161399154
31 Mar 171,621152396151
31 Dec 161,611154394148
30 Sep 161,619146393148
30 Jun 161,621111393144
31 Mar 161,646119390145
31 Dec 151,624102392146
30 Sep 151,65466408151
30 Jun 151,67760420158
31 Mar 151,73955436165
31 Dec 141,80957451174
30 Sep 141,85366451182
30 Jun 141,87277449185
31 Mar 141,87083441187

Quality Earnings: B2RK34 has high quality earnings.

Growing Profit Margin: B2RK34's current net profit margins (9.4%) are lower than last year (11.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: B2RK34's earnings have grown by 16.3% per year over the past 5 years.

Accelerating Growth: B2RK34's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: B2RK34 had negative earnings growth (-4.5%) over the past year, making it difficult to compare to the Life Sciences industry average (-0.9%).

Return on Equity

High ROE: B2RK34's Return on Equity (16.5%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/31 21:12
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bruker Corporation is covered by 35 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Luke SergottBarclays
Michael RyskinBofA Global Research
Derik de BruinBofA Global Research